Abstract:Aims: Studies on cancer biology have shown that overexpression of oncogenes (with or without functional loss of tumor suppressor genes), which is responsible for the progression of human malignancies via a multistep process, may be reduced by antisense technology. Caffeine enhances the effect of cisplatin (CDDP) chemotherapy on osteosarcoma cells. We constructed the recombinant adenovirus (Myc-AS) encoding the antisense c-myc fragment and investigated the synergic effect of caffeine and Myc-AS on the in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin. Methods: The recombinant adenovirus (Myc-AS) encoding the antisense c-myc fragment was constructed by cloning c-myc cDNA of about 750 bp in a reverse direction into adenovirus vector, then undergoing recombination, amplification and complementation in vivo. Myc-AS and caffeine were used either alone or in combination with CDDP to treat osteosarcoma MG-63 cells in vitro. Western blot, MTT, flow cytometry (FCM) and electron microscopy were used to evaluate the expression of c-myc protein, tumor cell proliferation in vitro and apoptosis and to perform cell cycle analysis. Results: Myc-AS encoding antisense c-myc fragment was obtained with a titer of 2 x 10(9) pfu/ml. Myc-AS downregulated the expression of c-myc protein after transfecting MG-63 cells for 48 h, induced tumor cell apoptosis and inhibited tumor cell proliferation in vitro. Myc-AS or caffeine can enhance the cytotoxic effects of 2.0 and 5.0 mu g/ml CDDP on MG-63 cells. Moreover, the significantly enhancing effect of the Myc-AS-caffeine combination on CDDP chemotherapy of MG-63 cells was not restricted to apoptosis but also decreased tumor cell proliferation in vitro. Expression of the apoptosis-associated bcl-2 gene was downregulated and bax was upregulated, with no changes in E2F-1 expression. FCM analysis showed that CDDP treatment induced a block in S phase, and caffeine reversed this block and accelerated cell progression through the S phase. Conclusions: Myc-AS can induce obvious G2/M phase arrest in transfected cells. Myc-AS combined with caffeine can enhance apoptosis induction and chemotherapeutic effects of CDDP on osteosarcoma MG-63 cells. Copyright (C) 2009 S. Karger AG, Basel

The differential effect of AICAR on c-Myc expression and proliferation in specific tumor cell lines

[Effect of AMPK Agonist 5-Aminoimidazole-4-carboxamide Ribonucleoside on Proliferation, Differentiation and Apoptosis in U937 Cells].

The Effect of AICAR on Rat Uterine Smooth Muscle

AMPK Activator AICAR Promotes 5-Fu-induced Apoptosis in Gastric Cancer Cells

AICAR Inhibits Proliferation and Induced S-phase Arrest, and Promotes Apoptosis in CaSki Cells

Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

AICAR Suppresses Cell Proliferation and Synergizes with Decitabine in Myelodysplastic Syndrome Via DNA Damage Induction.

EFFECTS OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA CELL LINES AND ITS MECHANISM

Abstract 451: AICAR targets oncogenic signaling pathways of MUC1-CT

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.

Effect Of Chronic Aicar Treatment On Muscle Fiber Composition And Enzyme Activity In Skeletal Muscle Of Rats

AICAR Represses the Proliferation of Mouse F9 Cell by Activating Foxc1 Signaling

The Full Capacity of Aicar to Reduce Obesity-Induced Inflammation and Insulin Resistance Requires Myeloid Sirt1

AICAr Suppresses Cell Proliferation by Inducing NTP and Dntp Pool Imbalances in Acute Lymphoblastic Leukemia Cells

AICAR Induces AMPK-Independent Cell Death in Adult T-Cell Leukemia/Lymphoma and Has Anti-Tumor Activity

Quantification of AICAR and study of metabolic markers after administration

Inhibition of Ciap1 As a Strategy for Targeting C-Myc-driven Oncogenic Activity.

ATRA with C-Myc RNA Interference Inhibits Cell Growth and Induces Apoptosis of Lung Adenocarcinoma

Experimental Study of the Expression of ICAM-1 of Breast Cancer Cells Induced by Cell Differentiation Agent-Uroacitides